News & Updates

In a meta-analysis conducted by researchers from the National University of Singapore, isotretinoin use was not associated with increased risk of suicide or psychiatric conditions.

Vaccination against hepatitis E appears to provide up to 10 years of protection, with vaccine-induced antibodies persisting for at least 8.5 years, as shown in a study from China.

In people living with HIV (PWH) who are at low-to-moderate risk of cardiovascular disease (CVD), use of pitavastatin for 2 years leads to a reduction in noncalcified plaque volume and progression, which potentially contributes to a decrease in major adverse cardiovascular events (MACE), according to the results of the mechanistic substudy of the REPRIEVE trial.

Combination treatment with durvalumab plus FLOT (fluorouracil, leucovorin, oxaliplatin, docetaxel) leads to higher rates of pathologic complete response (pCR) in patients with resectable gastric cancer (GC) or gastroesophageal junction cancer (GEJC), with the benefit universally observed regardless of geographic location, according to the subgroup analysis of the phase III MATTERHORN study.

Some pieces of evidence suggest the significant association of cannabis use with heroin use at earlier follow-ups of the ATOS*, but these data are scant and inconsistent across time points, reports a study.

Prophylactic apixaban appears to effectively reduce the risk of venous thromboembolism (VTE) for patients undergoing open surgery for gynaecologic malignancies and should be considered the standard of care for VTE prophylaxis in this population, according to a retrospective study.